Why “reprogramming” is the buzziest approach to reversing aging right now

MIT Technology Reviewby Jessica Hamzeloutech

Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…

This article was published on MIT Technology Review (technologyreview.com). Read the full article on the original source:

Read full article on MIT Technology Review

More from MIT Technology Review